126 related articles for article (PubMed ID: 32896797)
1. Combination of MS Binding Assays and affinity selection mass spectrometry for screening of structurally homogenous libraries as exemplified for a focused oxime library addressing the neuronal GABA transporter 1.
Gabriel J; Höfner G; Wanner KT
Eur J Med Chem; 2020 Nov; 206():112598. PubMed ID: 32896797
[TBL] [Abstract][Full Text] [Related]
2. Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1.
Kern FT; Wanner KT
ChemMedChem; 2015 Feb; 10(2):396-410. PubMed ID: 25369775
[TBL] [Abstract][Full Text] [Related]
3. A Library Screening Strategy Combining the Concepts of MS Binding Assays and Affinity Selection Mass Spectrometry.
Gabriel J; Höfner G; Wanner KT
Front Chem; 2019; 7():665. PubMed ID: 31637233
[TBL] [Abstract][Full Text] [Related]
4. Library screening by means of mass spectrometry (MS) binding assays-exemplarily demonstrated for a pseudostatic library addressing γ-aminobutyric acid (GABA) transporter 1 (GAT1).
Sindelar M; Wanner KT
ChemMedChem; 2012 Sep; 7(9):1678-90. PubMed ID: 22689508
[TBL] [Abstract][Full Text] [Related]
5. Identification of Pyrrolidine-3-acetic Acid Derived Oximes as Potent Inhibitors of γ-Aminobutyric Acid Transporter 1 through Library Screening with MS Binding Assays.
Huber SK; Höfner G; Wanner KT
ChemMedChem; 2018 Dec; 13(23):2488-2503. PubMed ID: 30485691
[TBL] [Abstract][Full Text] [Related]
6. Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
Huber SK; Höfner G; Wanner KT
Bioorg Med Chem; 2019 Jul; 27(13):2753-2763. PubMed ID: 31097402
[TBL] [Abstract][Full Text] [Related]
7. Screening oxime libraries by means of mass spectrometry (MS) binding assays: Identification of new highly potent inhibitors to optimized inhibitors γ-aminobutyric acid transporter 1.
Kern F; Wanner KT
Bioorg Med Chem; 2019 Apr; 27(7):1232-1245. PubMed ID: 30777661
[TBL] [Abstract][Full Text] [Related]
8. Novel Allosteric Ligands of γ-Aminobutyric Acid Transporter 1 (GAT1) by MS Based Screening of Pseudostatic Hydrazone Libraries.
Hauke TJ; Wein T; Höfner G; Wanner KT
J Med Chem; 2018 Nov; 61(22):10310-10332. PubMed ID: 30376325
[TBL] [Abstract][Full Text] [Related]
9. MS-Based Screening of 5-Substituted Nipecotic Acid Derived Hydrazone Libraries as Ligands of the GABA Transporter 1.
Hauke TJ; Höfner G; Wanner KT
ChemMedChem; 2019 Mar; 14(5):583-593. PubMed ID: 30663849
[TBL] [Abstract][Full Text] [Related]
10. Using short columns to speed up LC-MS quantification in MS binding assays.
Höfner G; Wanner KT
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1356-64. PubMed ID: 20036623
[TBL] [Abstract][Full Text] [Related]
11. Focused pseudostatic hydrazone libraries screened by mass spectrometry binding assay: optimizing affinities toward γ-aminobutyric acid transporter 1.
Sindelar M; Lutz TA; Petrera M; Wanner KT
J Med Chem; 2013 Feb; 56(3):1323-40. PubMed ID: 23336362
[TBL] [Abstract][Full Text] [Related]
12. Expanding the scope of MS binding assays to low-affinity markers as exemplified for mGAT1.
Zepperitz C; Höfner G; Wanner KT
Anal Bioanal Chem; 2008 May; 391(1):309-16. PubMed ID: 18345533
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an LC-ESI-MS/MS quantification method for a potential γ-aminobutyric acid transporter 3 (GAT3) marker and its application in preliminary MS binding assays.
Polley M; Höfner G; Wanner KT
Biomed Chromatogr; 2013 May; 27(5):641-54. PubMed ID: 23225341
[TBL] [Abstract][Full Text] [Related]
14. Application of MS Transport Assays to the Four Human γ-Aminobutyric Acid Transporters.
Schmitt S; Höfner G; Wanner KT
ChemMedChem; 2015 Sep; 10(9):1498-510. PubMed ID: 26220444
[TBL] [Abstract][Full Text] [Related]
15. GABA transporters regulate tonic and synaptic GABA
Moldavan M; Cravetchi O; Allen CN
J Neurophysiol; 2017 Dec; 118(6):3092-3106. PubMed ID: 28855287
[TBL] [Abstract][Full Text] [Related]
16. Advancing ASMS with LC-MS/MS for the discovery of novel PDCL2 ligands from DNA-encoded chemical library selections.
Ye Q; Belabed H; Wang Y; Yu Z; Palaniappan M; Li JY; Kalovidouris SA; MacKenzie KR; Teng M; Young DW; Fujihara Y; Matzuk MM
Andrology; 2023 Jul; 11(5):808-815. PubMed ID: 36209044
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an LC-ESI-MS/MS method for the quantification of D-84, reboxetine and citalopram for their use in MS Binding Assays addressing the monoamine transporters hDAT, hSERT and hNET.
Neiens P; De Simone A; Ramershoven A; Höfner G; Allmendinger L; Wanner KT
Biomed Chromatogr; 2018 Jul; 32(7):e4231. PubMed ID: 29500932
[TBL] [Abstract][Full Text] [Related]
18. Application of affinity selection-mass spectrometry assays to purification and affinity-based screening of the chemokine receptor CXCR4.
Whitehurst CE; Yao Z; Murphy D; Zhang M; Taremi S; Wojcik L; Strizki JM; Bracken JD; Cheng CC; Yang X; Shipps GW; Ziebell M; Nickbarg E
Comb Chem High Throughput Screen; 2012 Jul; 15(6):473-85. PubMed ID: 22651846
[TBL] [Abstract][Full Text] [Related]
19. MS-binding assays: kinetic, saturation, and competitive experiments based on quantitation of bound marker as exemplified by the GABA transporter mGAT1.
Zepperitz C; Höfner G; Wanner KT
ChemMedChem; 2006 Feb; 1(2):208-17. PubMed ID: 16892353
[TBL] [Abstract][Full Text] [Related]
20. GABA transporter-1 inhibitor NO-711 alters the EEG power spectra and enhances non-rapid eye movement sleep during the active phase in mice.
Xu XH; Qiu MH; Dong H; Qu WM; Urade Y; Huang ZL
Eur Neuropsychopharmacol; 2014 Apr; 24(4):585-94. PubMed ID: 24080505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
